safety steps

Medical Benefits Scheme (MBS) Addresses Lantus (Insulin Glargine) Shortages, Ensures Full Stock Availability and confirms that there are no shortages of medications.

The Medical Benefits Scheme (MBS) reaffirms its commitment to providing essential medications to its beneficiaries for the effective management of chronic conditions.

MBS allocates approximately nineteen million Eastern Caribbean dollars towards procuring pharmaceuticals, catering to eleven chronic conditions, including hypertension, diabetes, cancer, and cardiovascular diseases.

MBS beneficiaries can rest assured that the required medication for the management of their chronic conditions is available and accessible through the MBS network of pharmacies.

However, we acknowledge a recent challenge related to the availability of Lantus (Insulin Glargine) – one of the insulin types included in the MBS Formulary.
During the week of January 15, 2024, both presentations of Lantus (vials and Pens/cartridges) registered zero stock at the Central Procurement Unit.

This shortage was a consequence of the global supply issues previously addressed
in our August 2023 Press Release, impacting not only Antigua & Barbuda but also the wider Caribbean.

On January 16, 2024, MBS Pharmacies received limited stocks with 33 pens available at Clare Hall Pharmacy and 6 pens at Bolans Pharmacy. Some private pharmacies also had restricted supplies.

Patients facing an immediate shortage were given the option to purchase the required insulin at private pharmacies, with full reimbursement. For those in need, physicians were contacted to explore alternative insulin options.

In response to the shortage, MBS took proactive measures, and a shipment of Lantus (both presentations) was received on January 30, 2024. By January 31, 2024, all MBS Pharmacies were fully restocked, ensuring that beneficiaries can now access the required medication without any interruption.

With a focus on the well-being of the community, MBS continues to navigate global challenges to deliver quality healthcare services.

The Medical Benefits Scheme is committed to providing comprehensive healthcare solutions to its beneficiaries, ensuring access to vital medications for the effective management of chronic conditions.

We assure our beneficiaries that the medication necessary for managing chronic conditions is readily available and can be sourced from the MBS network of pharmacies.